‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s
Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the ... read more
Source: Parkinson’s Life EUPublished on 2020-02-27By admin